U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H15N3O5
Molecular Weight 305.286
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ENTACAPONE

SMILES

CCN(CC)C(=O)C(\C#N)=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O

InChI

InChIKey=JRURYQJSLYLRLN-BJMVGYQFSA-N
InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+

HIDE SMILES / InChI
Molecular Formula C14H15N3O5
Molecular Weight 305.286
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:56:16 UTC 2023
Edited
by admin
on Fri Dec 15 15:56:16 UTC 2023
Record UNII
4975G9NM6T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ENTACAPONE
EMA EPAR   EP   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP-RS   VANDF   WHO-DD  
INN   USAN  
Official Name English
OR-611
Code English
Entacapone [WHO-DD]
Common Name English
ENTACAPONE [EP MONOGRAPH]
Common Name English
COMTAN
Brand Name English
COMTESS
Brand Name English
CORBILTA COMPONENT ENTACAPONE
Brand Name English
ENTACAPONE [ORANGE BOOK]
Common Name English
ENTACAPONE [JAN]
Common Name English
ENTACAPONE COMPONENT OF STALEVO
Brand Name English
ENTACAPONE COMPONENT OF CORBILTA
Brand Name English
ENTACAPONE [MI]
Common Name English
ENTACAPONE COMPONENT OF LEVODOPA/CARBIDOPA/ENTACAPONE ORION
Brand Name English
ENTACAPONE [USP-RS]
Common Name English
entacapone [INN]
Common Name English
(E)-.ALPHA.-CYANO-N,N-DIETHYL-3,4-DIHYDROXY-5-NITROCINNAMAMIDE
Systematic Name English
ENTACAPONE [MART.]
Common Name English
LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT ENTACAPONE
Brand Name English
ENTACAPONE [EMA EPAR]
Common Name English
ENTACAPONE [USP MONOGRAPH]
Common Name English
STALEVO COMPONENT ENTACAPONE
Brand Name English
ENTACAPONE [USAN]
Common Name English
ENTACAPONE [VANDF]
Common Name English
ENTACAPONE TEVA
Brand Name English
ENTACAPONE ORION
Brand Name English
2-PROPENAMIDE, 2-CYANO-3-(3,4-DIHYDROXY-5-NITROPHENYL)-N,N-DIETHYL-
Systematic Name English
Classification Tree Code System Code
NDF-RT N0000175756
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS STALEVO (AUTHORIZED: PARKINSON DISEASE)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
NDF-RT N0000175757
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS CORBILTA (AUTHORIZED: NERVOUS SYSTEM DISEASES)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS LEVODOPA/CARBIDOPA/ENTACAPONE ORION (AUTHORIZED: PARKINSON DISEASE)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS COMTESS (AUTHORIZED: PARKINSON DISEASE)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
LIVERTOX NBK548152
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS ENTACAPONE ORION (AUTHORIZED: PARKINSON DISEASE)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS CORBILTA (AUTHORIZED: PARKINSON DISEASE)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
WHO-ATC N04BX02
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS ENTACAPONE TEVA (AUTHORIZED: PARKINSON DISEASE)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
WHO-VATC QN04BX02
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
NCI_THESAURUS C38149
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
EMA ASSESSMENT REPORTS COMTAN (AUTHORIZED: PARKINSON DISEASE)
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
Code System Code Type Description
DRUG CENTRAL
1018
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
INN
6812
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
MESH
C071192
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
USAN
JJ-100
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
EVMPD
SUB06552MIG
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
SMS_ID
100000085408
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
RS_ITEM_NUM
1235933
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
DRUG BANK
DB00494
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
CHEBI
4798
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
RXCUI
60307
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY RxNorm
FDA UNII
4975G9NM6T
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
CAS
130929-57-6
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
DAILYMED
4975G9NM6T
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
IUPHAR
6647
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
WIKIPEDIA
ENTACAPONE
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
HSDB
8251
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
PUBCHEM
5281081
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
ChEMBL
CHEMBL953
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
MERCK INDEX
m4918
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY Merck Index
LACTMED
Entacapone
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
NCI_THESAURUS
C61746
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
EPA CompTox
DTXSID5046439
Created by admin on Fri Dec 15 15:56:17 UTC 2023 , Edited by admin on Fri Dec 15 15:56:17 UTC 2023
PRIMARY
Related Record Type Details
Structure of ENTACAPONE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
EP
OAT-2
TRANSPORTER -> INHIBITOR
IC50
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
CATECHOL O-METHYLTRANSFERASE
TARGET -> INHIBITOR
Structure of ENTACAPONE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
USP
Related Record Type Details
Structure of ENTACAPONE 3-O-GLUCURONIDE
METABOLITE -> PARENT
MAJOR
URINE
Structure of ENTACAPONE, (Z)-
METABOLITE -> PARENT
Active in vitro,but contribution should be little due to low plasma level
PLASMA
Related Record Type Details
Structure of ENTACAPONE 3-METHYL ETHER
IMPURITY -> PARENT
Structure of DESETHYL-ENTACAPONE
IMPURITY -> PARENT
Structure of ENTACAPONE, (Z)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of DENITROENTACAPONE
IMPURITY -> PARENT
Structure of ENTACAPONE, (Z)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
Structure of ENTACAPONE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966